Lee's Pharmaceutical Holdings (STU:L1PA) Change In Inventory : €0.0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Lee's Pharmaceutical Holdings Change In Inventory?

Lee's Pharmaceutical Holdings's change in inventory for the quarter that ended in Jun. 2024 was €0.0 Mil. It means Lee's Pharmaceutical Holdings's inventory stayed the same from Dec. 2023 to Jun. 2024 .

Lee's Pharmaceutical Holdings's change in inventory for the fiscal year that ended in Dec. 2023 was €-7.3 Mil. It means Lee's Pharmaceutical Holdings's inventory increased by €7.3 Mil from Dec. 2022 to Dec. 2023 .

Lee's Pharmaceutical Holdings's Total Inventories for the quarter that ended in Jun. 2024 was €27.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Lee's Pharmaceutical Holdings's Days Inventory for the quarter that ended in Jun. 2024 was 154.57.

Inventory Turnover measures how fast the company turns over its inventory within a year. Lee's Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Jun. 2024 was 1.18.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lee's Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.40.

Lee's Pharmaceutical Holdings Change In Inventory Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings Change In Inventory Chart

Lee's Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-6.14

-15.64

4.92

5.25

-7.28

Lee's Pharmaceutical Holdings Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Lee's Pharmaceutical Holdings Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

Lee's Pharmaceutical Holdings (STU:L1PA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lee's Pharmaceutical Holdings's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	31.0045	/	36.607	*	365 / 2
	=	154.57

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lee's Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	36.607	/	31.0045
	=	1.18

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lee's Pharmaceutical Holdings's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	31.0045	/	78.31
	=	0.40

Lee's Pharmaceutical Holdings Change In Inventory Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Lee's Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (STU:L1PA) » Definitions » Change In Inventory

Traded in Other Exchanges

LPCUF:USA 00950:Hong Kong L1PA:Germany

Address

Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG

Website

https://www.leespharm.com

Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines